SAN DIEGO, May 19, 2008 (PRIME NEWSWIRE) -- Mauna Kea Technologies, a leader in in vivo cellular imaging, today announced that leading international gastroenterologists presented data from four clinical studies on Cellvizio(r) GI at the Digestive Disease Week(r) (DDW) 2008 conference in San Diego. The reported data demonstrate Cellvizio GI’s value in diagnosing colorectal cancer as well as other gastrointestinal diseases. A fundamentally new endoscopic imaging approach, Cellvizio could improve patient care by eliminating unnecessary biopsies and could further improve diagnostic rates across a broad range of diseases.
